Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

L&T Finance stock price has been consolidating in a range for the last couple of months and has formed a ‘Diamond Pattern’ on ...

Citi reduced its Kalyan Jewellers target price from Rs 810 to Rs 650, implying a return potential of 47.5% over Thursday's close.

The company has a predicted growth of -100.00% for revenue & -100.00% in profit for the quarter . IREDA Share Price Live Updates: Today, IREDA's share price increased by 0.27%, reaching ₹187.40, while ...

AM, a combined 213,000 equity shares had changed hands on the counter and there were pending sell orders for 210,000 shares ...

Consensus analysts rating is Hold IREDA Live Updates: The analyst recommendation trend is shown below with the current rating as Hold. IREDA Share Price Live Updates: The share price of IREDA ...

IREDA approved the fund raising subject to condition that the Govt's stake would not reduce by more than 7% of total paid-up capital.

Government's shareholding in Ireda would not dilute by more than 7 per cent of its 75 per cent stake in the firm, the company ...

IREDA board approves fundraise of up to Rs 5,000 crore via QIP, shares crack Discover the latest Business News, Budget 2025 ...

Then, she found Sunshine Home Share, which conducted its own reference and criminal background checks. She met a few people who weren’t a good fit (including a woman who’d come to live with ...

The agreement for the 900 MW Upper Karnali hydro-electric project was formalised in New Delhi on Thursday, in the presence of senior officials from IREDA, SJVN, and GMR Energy. In a statement on ...

Shares of IREDA broke a two-day losing streak, rising more than 5% to Rs 212 per share on January 13, following strong guidance from the management and an announcement of a target timeline for a Rs ...